We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Synthetic Printed Implants Prompt Spinal Regeneration in Model

By LabMedica International staff writers
Posted on 31 Jan 2019
Print article
Image: A three-dimensional printed, two-millimeter implant used as scaffolding to repair spinal cord injuries in rats. The circles surrounding the H-shaped core are hollow portals through which implanted neural stem cells can extend axons into host tissues (Photo courtesy of Jacob Koffler and Wei Zhu, University of California, San Diego).
Image: A three-dimensional printed, two-millimeter implant used as scaffolding to repair spinal cord injuries in rats. The circles surrounding the H-shaped core are hollow portals through which implanted neural stem cells can extend axons into host tissues (Photo courtesy of Jacob Koffler and Wei Zhu, University of California, San Diego).
The potential use of three-dimensional (3D) printing to produce replacement components for the repair of spinal damage was demonstrated in a rat model system.

Up to now, three-dimensional printing of central nervous system (CNS) structures has not been accomplished, possibly owing to the complexity of CNS architecture. To rectify this situation, investigators at the University of California, San Diego (USA) used a three-dimensional microscale continuous projection printing method (MuCPP) to create a complex CNS structure for regenerative medicine applications in the spinal cord.

The MuCPP method enabled printing of three-dimensional biomimetic hydrogel scaffolds that were tailored to the dimensions of the rodent spinal cord. This process required only 1.6 seconds and was scalable to human spinal cord sizes and lesion geometries. In this regard, four-centimeter-sized implants modeled from MRI scans of actual human spinal cord injuries were printed within 10 minutes. The printed scaffolds contained dozens of 200-micrometer-wide channels that guided neural stem cell and axon growth along the length of the spinal cord injury.

The investigators tested the ability of MuCPP three-dimensional-printed scaffolds loaded with neural progenitor cells (NPCs) to support axon regeneration and form new "neural relays" across sites of complete spinal cord injury in vivo in rodents.

They reported in the January 14, 2019, online edition of the journal Nature Medicine that injured host axons regenerated into three-dimensional biomimetic scaffolds and synapsed onto NPCs implanted into the device. Implanted NPCs in turn extended axons out of the scaffold and into the host spinal cord below the injury to restore synaptic transmission and significantly improve the animal's ability to move.

"In recent years and papers, we have progressively moved closer to the goal of abundant, long-distance regeneration of injured axons in spinal cord injury, which is fundamental to any true restoration of physical function," said senior author Dr. Mark Tuszynski, professor of neuroscience at the University of California, San Diego.

Related Links:
University of California, San Diego

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.